Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Parallel Session 4418

Imaging the Future of Parkinsonian Disorders: Tracking Disease and Therapies

Wednesday, October 8, 2025
14:00 - 15:30 | Room TBD

In this session, the faculty will discuss current and future imaging biomarkers in parkinsonian disorders, and present advances in molecular imaging. An update on the value of translational imaging concepts will be highlighted.


Chairs:

Irena Rektorova, Czech Republic
Thilo Van Eimeren, Germany

Presenters:

Neuroimaging Biomarkers
Benedicte Ballanger, France

Tracking a-Synuclein and Tau Pathology
Hironobu Endo, Japan

The Role of Imaging in Clinical Trials
Nicola Pavese, United Kingdom

CSPC Liaisons:

Irena Rektorova, Czech Republic

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Describe neuroimaging biomarkers for diagnosis of parkinsonian disorders and for tracking disease progression
  2. Describe clinical and research applications of molecular imaging in parkinsonian disorders
  3. Discuss imaging methods for assessing target engagement in clinical trials and principles, application and pitfalls of ‘radiomics’ in complex data analysis

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Intermediate / Experienced

Focus

Clinical
Translational